Browse By: Country ι Category ι Publisher ι Tag

Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition

Pages » 208
Published By » JustPharmaReports.com
Price » $2350
In stock
View Report Details
Description

The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. But is this enough to assure premium prices and special status in an era of budget limitations, and growing demands for evidence of clinical and cost effectiveness? Payers are becoming increasingly strict. Four of the first seven orphan drugs to enter Germany’s AMNOG procedure were considered to bring only minor additional benefit and for two others the benefit was deemed non-quantifiable....


Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2011 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only h
Published Date: Jun 2011
Price: $2300
Market Access Korea: Breaking into the Developed World\'s Fastest Growing Pharmaceutical Market
South Korea as a country has been an economic success story and the origin of much cutting edge technology, but its pharmaceutical market can now also be given ‘Asian tiger’ status. The past four years have seen total sales growth of 15.6%, 13.5%, 12.4% and 13.8% respectively. IMS
Published Date: Nov 2010
Price: $1380
Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access
A major new report Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia. Each has passed specific measures to promote the development, registration and/or commer
Published Date: Feb 2010
Price: $2320
Biosimilars: Current Situation & Future Prospects, Worldwide
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global biologics market expected to lose some degree of protection by 2019. All major countr
Published Date: Mar 2012
Price: $3000
Pharmaceutical Pricing & Distribution in Japan, 2010 Update
The author’s 2008 major title ‘Pharmaceutical Pricing & Distribution in Japan’ was described by PhRMA Japan as ‘a superb report…to understand Japan there is nothing better’. His new report packs all the essentials needed to optimise market access and life
Published Date: Oct 2011
Price: $760
Pharmaceutical Pricing & Distribution in Japan, 2012 Update
No serious pharmaceutical company can afford to ignore Japan, a $120 billion market, the second-largest in the world. It remains a tough and highly competitive market to crack, however, with the environment for developing and marketing medicines dominated by price.  No new bran
Published Date: Jun 2012
Price: $1400
Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
Managed entry agreements apply to an increasing number of new, innovative drugs in a growing number of markets. They are designed to share the risk between the manufacturer and the payer, consequent on uncertainties - usually at launch - about the product’s value (clinical- and cost-effect
Published Date: Feb 2013
Price: $1050
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. B
Published Date: Oct 2013
Price: $2350

 


 

Related News

Beverages and snack report organic growth in Q2 for PepsiCo
PepsiCo, the popular snacks and beverages manufacturer posted a growth of 0.5% in its net revenue of Q2. The company’s organic revenue rose by 3.6% during the same period. The rise was in line with the expectations of snacks contributing beyond half the net sales. The snacks division which constitutes about 60% of Pepsico’s valuation grew by 5% for the snacks, organically. The non-sparkling drinks such as energy drinks, teas, coffee, and other health related drinks showed steady gro
Date: Jul 31

Ericsson Acquires American Metadata-based Billing Technologies Provider
Swedish vendor Ericsson has signed a deal to acquire American metadata-based commerce tools provider in a bid to strengthen its presence across various business verticals. MetraTech provides billing, settlement, and other commerce-related tools that can easily be integrated into a myriad of business models. The acquisition is not specifically pertinent to Ericsson’s telecom business, but will aid its portfolio expansion strategy. Financial details of the deal were not disclosed immediately
Date: Jul 31

Wealth Managers Strive for Next-Gen Automation Systems for High Efficiency
The need to balance regulatory pressures along with ongoing conditions is a big challenge for wealth management firms. An industry research provided by ComPeer highlighted the importance of compliance as one of the only three departments in the industrial sector that has increased staff numbers in the year 2012.  However, with rising demands and high resources, firms are under constant pressure to find more effective ways to serve better services.  The wealth management sector is
Date: Jul 31

TouchStars Growth and Achievements in Fleet Refueling and Fuel Distribution Industry
TouchStar recently announced about its fuel distribution client base expansion in the United States. TouchStar is an international provider of mobility software solutions and logistics that is now driven by the addition of two new clients in the market.  The company is represented by a Californian regional fuel and lubricant distributor and a regional fuel distributor based in Mississippi. Both specialize in fleet refueling increasing with a total fleet of above 20,000 vehicles. The fuel d
Date: Jul 30

ST Launches MEMS Microphone Test Facility in Taipei
STMicroelectronics NV has announced the establishment of an anechoic chamber, which the company intends to use in developing MEMS microphone applications. The facility, located in Taipei, Taiwan, has been set up with a particular focus on improving audio performance across applications. STMicroelectronics has indicated its keenness on working towards achieving industry-leading audio performance across all system levels, from tablets, smartphones, televisions, notebook computers, remote controls
Date: Jul 30

Patients with dementia more likely to be implanted with pacemaker: Study
Patients with dementia are significantly more likely to get pacemakers than those without any cognitive deficits, a recently published study states. Although the study cannot explain exactly why people with dementia are more likely to be implanted with the devices, researchers speculate that the probability of dementia patients seeking medical care more often is higher than people without cognitive impairments. Dr Nicole Fowler, the lead author, states that frequency of visits and more involveme
Date: Jul 29

Société Générale Private Banking picks Wolters Kluwer Financial Services for risk management and regulatory reporting
Société Générale Private Banking has selected Wolters Kluwer Financial services to help the former with facilitating compliance with Capital Requirements Directive IV in Belgium. Wolters will provide solutions such as regulatory reporting and risk management. The solution partner will provide the bank with risk analyses of liquidity and counterparty credit, capital, automated reports of COREP XBRL returns. Previously too, Société Générale
Date: Jul 29

Chemical Resistant Gloves by Ansell Industrial Healthcare provides sturdy Grip
Oils and degreasers are common elements found in any industrial area used for the removal of lubricants and oils from different metal parts. It is a critical part of the manufacturing and processing operation in every field. To handle such chemicals and degreasing agents one needs to wear proper hand protection gloves so as to avoid any kind of toxic reactions and direct contact with skin.  Ansell Industrial Healthcare has specifically designed a range of industrial gloves that offer eff
Date: Jul 29

JTI persuades Malawi in Tobacco Industry Reformations
JTI Leaf Malawi - Malawi’s leading Tobacco Company partnered with its country’s government in the drive to transform the tobacco industry. It has committed with Malawi Government, its stakeholders, and growers for the same cause. This transformation is alleged to reinforce Malawi’s socio-economic development.  Malawi’s Minister of Agriculture Allan Chiyembekeza toured the JTI’s offices, and viewed the state-of-the-art facilities and warehousing and processing
Date: Jul 29

Wipro plans hiring from IITs and NITs
In a bid to build a strong, well-educated workforce that will be capable to taking on leadership challenges in the coming future, Wipro plans to hire from NITs and IITs. These recruits are envisioned to herald the latest technologies such as automation, mobility, cloud, and analytics. The recruitment drive, Star program, which hires about 100 engineers from NITs and IITs intends to raise this number. As these new recruits are hired at different salary slabs, each is given the liberty to chart t
Date: Jul 28

Upcoming Reports

Antiemetic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Antiemetics are therapeutic agents which are used to treat vomiting and nausea caused by several medical conditions. Nausea and vomiting are not diseases, they are symptoms associated with a variety of medical conditions such as gastroenteritis, motion sickness, dizziness, pregnancy, overeating, emo
Published By: Transparency Market Research
Price: $4795
Alzheimers Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Alzheimer’s disease is a neurological disorder of the brain which is progressive and ultimately leads to loss of neurons. This condition leads to loss of memory and reasoning abilities. Currently, there is no treatment for Alzheimer’s, although there are certain ways of slowing down it
Published By: Transparency Market Research
Price: $4795
Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795